Abeona Therapeutics Q2 EPS $(0.26) Beats $(0.36) Estimate, Cash Balance $123M
Portfolio Pulse from Benzinga Newsdesk
Abeona Therapeutics reported a Q2 EPS of $(0.26), beating the estimate of $(0.36). The company also reported a cash balance of $123 million.
August 12, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abeona Therapeutics reported a Q2 EPS of $(0.26), beating the estimate of $(0.36). The company also reported a cash balance of $123 million.
Abeona Therapeutics' better-than-expected Q2 EPS and strong cash balance are positive indicators for the company's financial health, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100